Skip to content
PICO Portalanswers from OpenAlex

Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen

PaperCitations, authors & open-access status

Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen is a paper indexed in PICO Portal from OpenAlex.

How many citations does Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen have?

PICO Portalcitation count

Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen has 1 citations in the OpenAlex counts PICO Portal stores.

When was Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen published?

PICO Portalyear

Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen has 2026 year in the PICO Portal index.

What is the open-access status of Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen?

PICO Portaloa status

Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen has gold oa status in the PICO Portal index.

What is the DOI of Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen?

PICO Portaldoi

The DOI for Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen is on the source record.

What is the PMID of Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen?

PICO Portalpmid

The PMID for Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen is on the source record.

What is the OpenAlex record for Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen?

PICO Portalopenalex

The OpenAlex for Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial